Latest News about Briefs
Recent news which mentions Briefs
Cancer-Focused ESSA Pharma Ends Prostate Cancer Trial Due to Insufficient Efficacy From Combination Therapy
November 01, 2024
From Benzinga
LyondellBasell Q3 Results Miss Estimates, Signals Softer Demand And Rising Costs For Q4
November 01, 2024
From Benzinga
From Benzinga
From Benzinga
Nvidia's Run:ai Acquisition Draws European Regulatory Scrutiny On Competition Concerns
November 01, 2024
From Benzinga
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
FuboTV Q3 Earnings: Subscribers Grow 9% To 1.61 Million, Narrows EPS Loss, Raises Annual Outlook
November 01, 2024
From Benzinga
Dominion Energy Q3 Results: Revenue Miss, Earnings Beat, And Updated FY24 Guidance
November 01, 2024
From Benzinga
ArcBest Shares Fall On Q3 Revenue Miss, Productivity Gains Can't Offset Shipment Decline
November 01, 2024
From Benzinga
Charter Communications Beats Q3 Estimates On Strong Mobile Growth, Expanding Margins
November 01, 2024
From Benzinga
Cardinal Health Raises 2025 Profit Outlook Again, Helped By Strong Drug Distribution Business
November 01, 2024
From Benzinga
Exxon Q3 Earnings: $11.3 Billion Cost Savings, Rising Production, Dividend Hike And More
November 01, 2024
From Benzinga
Chevron Q3 Earnings: Production Boost By PDC Energy & Permian Basin, Targets $2-$3 Billion In Structural Savings By 2026
November 01, 2024
From Benzinga
Asia In Red, Europe Markets Gain; Crude Oil Rises 2.5% - Global Markets Today While US Slept
November 01, 2024
From Benzinga
Ford To Halt F-150 EV Production For 7 Weeks Next Month
October 31, 2024
From Benzinga
Starbucks Faces Sales Slump But Analysts See Silver Lining With New CEO's Efficiency Strategy
October 31, 2024
From Benzinga
From Benzinga
Sirius XM Q3 Earnings: Net Income Hit by $3.4 Billion Liberty Impairment Charge, Revises Annual Outlook By 1%
October 31, 2024
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
October 31, 2024
From Benzinga
From Benzinga
STMicroelectronics' Q3 Results Highlight Weak Automotive Demand, Gross Margin Squeeze: Details
October 31, 2024
From Benzinga
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
October 31, 2024
From Benzinga
Mastercard Q3 Earnings: Revenue And EPS Beat, Cross Border Transactions Growth, Sees European Consumer Confidence Improvement
October 31, 2024
From Benzinga
Ambev Q3 Sales Miss Expectations As Volume Growth Stalls; Shares Dip
October 31, 2024
From Benzinga
SolarWinds Q3 Earnings: Subscription Gains Drive Revenue, Raises Full-Year Forecast
October 31, 2024
From Benzinga
Altria Q3: Earnings Beat, NJOY Gains Ground, But Marlboro Loses Share In Shrinking Market
October 31, 2024
From Benzinga
TotalEnergies Boasts Strong Revenue Despite Q3 EPS Miss, Decline In LNG And Production
October 31, 2024
From Benzinga
Cheez It Parent Kellanova's Q3 Earnings: Organic Sales Climb, Mars Buyout Vote Nears & More
October 31, 2024
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.